 Comparative thrombolytic properties bolus injections continuous infusions chimeric t-PA/u-PA plasminogen activator hamster pulmonary embolism model recombinant chimeric plasminogen activator rt-PA-delta FE/scu-PA-e amino acids tissue-type plasminogen activator t-PA amino acids single-chain urokinase-type plasminogen activator scu-PA thrombolytic potency continuous intravenous infusion animal models venous thrombosis Collen Circulation press present study thrombolytic potencies intravenous bolus injections rt-PA-delta FE/scu-PA-e recombinant t-PA rt-PA recombinant scu-PA rscu-PA combination intravenous infusions hamster pulmonary embolism model Dose-dependent clot lysis absence systemic activation fibrinolytic system fibrinogen breakdown bolus injection experiments maximal rate clot lysis percent clot lysis compound rt-PA rscu-PA rt-PA-delta FE/scu-PA-e rt-PA rscu-PA Comparative results continuous infusion hour rt-PA rscu-PA percent lysis mg/kg compound rt-PA rscu-PA rt-PA-delta FE/scu-PA-e rt-PA rscu-PA potent infusion bolus whereas rt-PA-delta FE/scu-PA-e potent bolus bolus injections rt-PA rscu-PA synergistic effect clot lysis synergism combined bolus injections combined infusions rt-PA rt-PA-delta FE/scu-PA-e rscu-PA rt-PA-delta FE/scu-PA-e present study rt-PA-delta FE/scu-PA-e potent clot lysis rt-PA rscu-PA bolus injection synergistic interaction chimera rt-PA rscu-PA